Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,678
Total Claims
$1.8M
Drug Cost
773
Beneficiaries
$2,370
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+68%
Cost per patient vs peers
$2,370 vs $1,411 avg
+25%
Brand preference vs peers
13.3% vs 10.6% avg
Brand vs Generic
Brand: 1,924 claims · $1.5M
Generic: 12,526 claims · $304K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 228 | $324K |
| Empagliflozin | 147 | $211K |
| Semaglutide | 144 | $199K |
| Apixaban | 98 | $142K |
| Sitagliptin Phosphate | 92 | $99K |
| Insulin Glargine,hum.Rec.Anlog | 105 | $68K |
| Insulin Glargine,hum.Rec.Anlog | 109 | $64K |
| Bictegrav/Emtricit/Tenofov Ala | 11 | $40K |
| Rivaroxaban | 37 | $34K |
| Insulin Glargine,hum.Rec.Anlog | 82 | $32K |
| Dapagliflozin Propanediol | 27 | $30K |
| Atorvastatin Calcium | 1,370 | $28K |
| Fluticasone Propionate | 55 | $27K |
| Canagliflozin | 26 | $22K |
| Insulin Nph Hum/Reg Insulin Hm | 19 | $18K |
Prescribing Profile
Patient Profile
73
Avg Age
50%
Female
1.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data